Progress and challenges in viral vector-mediated gene transfer to the brain

Area of Science:

• Neuroscience
• Molecular Biology
• Gene Therapy

Background:

• Gene transfer enables precise manipulation of transgene expression in the brain.
• Current technologies allow targeting specific cell populations for altered gene expression.
• Applications include modifying neurotransmitter receptors, ion channels, and growth factors to impact brain function and pathology.

Purpose of the Study:

• To review the challenges and recent advancements in neuro-gene therapy for neurological diseases.
• To identify key areas requiring further development for clinical application.
• To highlight progress in overcoming barriers to effective brain gene therapy.

Main Methods:

• Review of recent literature on gene transfer technologies and viral vectors in neuroscience.
• Analysis of challenges in brain gene therapy, including vector delivery, diffusion, toxicity, and immune response.
• Evaluation of progress in achieving cell-type specific and controllable transgene expression.

Main Results:

• Gene therapy has demonstrated success in preventing and correcting brain defects in experimental models.
• Viral vectors and transgenes show improved diffusion over larger brain areas.
• Understanding and mitigating vector-induced inflammation and immune responses are advancing.

Conclusions:

• Significant progress has been made in neuro-gene therapy, with potential for treating neurological disorders.
• Further improvements in viral vectors are crucial for advancing clinical trials.
• Addressing challenges in delivery, expression control, and safety will enhance gene therapy's therapeutic potential.